Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
In Vivo Selection of anti-glioblastoma DNA aptamer-drug conjugates in an orthotopic patient-derived xenograft model.
Journal: bioRxiv : the preprint server for biology
Published: February 27, 2026
Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma.
Journal: JHEP reports : innovation in hepatology
Published: September 02, 2025
An unbiased cell-culture selection yields DNA aptamers as novel senescent cell-specific reagents.
Journal: bioRxiv : the preprint server for biology
Published: April 01, 2025
An Unbiased Cell-Culture Selection Yields DNA Aptamers as Novel Senescent Cell-Specific Reagents.
Journal: Aging cell
Published: March 27, 2025
Methods for cell- and tissue-specific DNA aptamer selection.
Journal: Molecular therapy. Methods & clinical development
Published: October 04, 2024
Aptamers in neuro-oncology: An emerging therapeutic modality.
Journal: Neuro-oncology
Published: August 24, 2023
A Novel P53 Nanomedicine Reduces Immunosuppression and Augments Anti-PD-1 Therapy for Non-Small Cell Lung Cancer in Syngeneic Mouse Models.
Journal: Cells
Published: September 02, 2022
Optimized quantitative PCR analysis of random DNA aptamer libraries.
Journal: Analytical biochemistry
Published: March 09, 2022
A tumor-targeting nanomedicine carrying the p53 gene crosses the blood-brain barrier and enhances anti-PD-1 immunotherapy in mouse models of glioblastoma.
Journal: International journal of cancer
Published: May 16, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026